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Abstract
Background: Clinical treatments with typical antipsychotic drugs (APDs) are accompanied by extrapyramidal motor side-
effects (EPS) such as hypokinesia and catalepsy. As little is known about electrophysiological substrates of such motor
disturbances, we investigated the effects of a typical APD, a-flupentixol, on the motor behavior and the neuronal activity of
the whole basal ganglia nuclei in the rat.
Methods and Findings: The motor behavior was examined by the open field actimeter and the neuronal activity of basal
ganglia nuclei was investigated using extracellular single unit recordings on urethane anesthetized rats. We show that a-
flupentixol induced EPS paralleled by a decrease in the firing rate and a disorganization of the firing pattern in both
substantia nigra pars reticulata (SNr) and subthalamic nucleus (STN). Furthermore, a-flupentixol induced an increase in the
firing rate of globus pallidus (GP) neurons. In the striatum, we recorded two populations of medium spiny neurons (MSNs)
after their antidromic identification. At basal level, both striato-pallidal and striato-nigral MSNs were found to be unaffected
by a-flupentixol. However, during electrical cortico-striatal activation only striato-pallidal, but not striato-nigral, MSNs were
found to be inhibited by a-flupentixol. Together, our results suggest that the changes in STN and SNr neuronal activity are a
consequence of increased neuronal activity of globus pallidus (GP). Indeed, after selective GP lesion, a-flupentixol failed to
induce EPS and to alter STN neuronal activity.
Conclusion: Our study reports strong evidence to show that hypokinesia and catalepsy induced by a-flupentixol are
triggered by dramatic changes occurring in basal ganglia network. We provide new insight into the key role of GP in the
pathophysiology of APD-induced EPS suggesting that the GP can be considered as a potential target for the treatment of
EPS.
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Introduction
Clinical treatments with typical antipsychotic drugs (APDs) are
accompanied by extrapyramidal motor side-effects (EPS). These
side-effects are supposed to be due to the dopaminergic antagonist
properties of APDs [1,2]. Accordingly, acute blockade of
dopamine transmission in rodent induce motor disturbances such
as hypokinesia and catalepsy. Most studies addressing possible sites
mediating EPS have been focused on the expression of immediate
early genes within the basal ganglia network [3,4], however, little is
known about the relationship between EPS and the changes in
basal ganglia neuronal activity.
The basal ganglia comprise a group of highly interconnected
subcortical nuclei that are intimately involved in the control of
movement. The striatum represents the principal input structure
of the basal ganglia and the substantia nigra pars reticulata (SNr) and
the entopeduncular nucleus (the equivalent of the internal globus
pallidus in primate) constitute the major output structures of the
basal ganglia projecting to the thalamus and the brainstem.
According to the current model of basal ganglia functional
organisation [5,6], input and output structures are linked via a
monosynaptic direct pathway and a polysynaptic indirect pathway
that involves the globus pallidus (GP) and the subthalamic nucleus
(STN). These two pathways arise from two different populations of
medium spiny neurons (MSNs) in the striatum (for review, [7]) [8].
The direct pathway is formed by GABAergic striato-nigral MSNs
expressing the peptides substance P, dynorphin, neurokinin A and
neurotensin and the indirect pathway is formed by GABAergic
striato-pallidal MSNs expressing enkephalin and neurokinin B.
These two direct and indirect pathways are differentially regulated
by dopamine through their respective expression of the excitatory
D1 and inhibitory D2 receptors.
Since typical APDs induce EPS and that the relationship
between these motor disabilities and changes in basal ganglia
neuronal activity has not been clearly established, the present
study aimed to investigate the effects of a typical APD, a-
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6208flupentixol, upon (i) behavioral motor activity and catalepsy
measured by an open field and the bar test respectively, and (ii)
extracellular single unit recordings of basal ganglia nuclei
including the GP, the STN, the SNr and antidromically identified
MSNs of the striatum.
Materials and Methods
Animals
Adult male Wistar rats, weighing 280–380 g were used for
behavioral and in vivo electrophysiological experiments. Animals
were provided by the ‘‘Centre d’Elevage Depre ´’’ (Saint Doulchard,
France) and arrived at least one week before use. They were housed
five per cage under artificial conditions of light (light/dark cycle,
light on at 7:00 a.m.), temperature (24uC), and humidity (45%) with
food and water available ad libitum. All animal experiments were
carried out in accordance with the European Communities Council
Directive of 24 November 1986 (86/609/EEC).
Lesion of the globus pallidus
As previously described [9,10], rats were placed in a stereotaxic
frame (Kopf, Unimecanique, France) under chloral hydrate
anaesthesia (400 mg/kg, i.p., Sigma). Each animal received a
unilateral injection of 0.4 ml ibotenic acid (Sigma, 8 mg/ml in
sterile PBS) into the globus pallidus at coordinates 1 mm posterior
to bregma, 3 mm lateral to the midline, and 6.5 mm below the
skull according to the brain atlas of Paxinos and Watson [11]. The
ibotenic acid injection was made over a 1 minute period of time
using a digital 10 ml Hamilton microsyringe. At the end of the
injection, the syringe needle was left in place for an additional 10
minutes and then withdrawn slowly to prevent reflux of the
solution.
Histological validation of the GP lesion. After completion
of experiments, fresh-frozen brains were cryostat-cut into coronal
20 mm sections for further validation of the extent of lesion using
Cresyl violet staining, as previously described [9,10]. Only those
brains in which a total or subtotal lesion of GP was observed were
used for data analysis, whereas animals with lesion outside of the
GP were excluded from the study.
Drug
a-flupentixol (2-[4-[3-[2-(trifluoromethyl)thioxanthen-9-ylide-
ne]propyl]piperazin-1-yl]ethanol) was purchased from Sigma
(Saint-Quentin Fallavier, France) and dissolved in NaCl 0.9%.
The dose of 0.3 mg/kg for intraperitoneal (i.p.) injection of a-
flupentixol was selected on the basis of a detailed litterature search,
showing a significant effect on spontaneous motor activity in the
rat [12,13].
Evaluation of motor activity (Open-field)
Spontaneous horizontal motor activity, vertical activity (or
rearing) and stereotyped movements (grooming, washing, and
other movements with low amplitudes and independant of
locomotor activity) were measured using a photoelectric actimeter
(Actitrack, Panlab, S.L., Barcelona, Spain), as previously described
[14,15]. Briefly, the apparatus consisted of a transparent cage that
was connected to a photoelectric cell. Light beams detected
movement and the total motor activity of each rat was recorded.
All testings in the actimeter were done in an isolated room
between 8:00 a.m. and 1:00 p.m. The protocol consisted of three
phases:
(A) Habituation: spontaneous motor activity was recorded
during four consecutive days in two consecutive sessions of 10
minutes, 50 minutes after i.p. injection of NaCl 0.9%. The first 10
minutes session was used to establish the daily habituation. Only
the motor activity recorded during the second session of 10
minutes was used for data analysis. Between-session habituation
was analysed by comparing behavior in the actimeter on day 3 vs
that on day 4.
(B) Challenge: a-flupentixol (0.3 mg/kg, i.p.) was injected on
day 5, 50 minutes prior the mesurement of motor activity.
(C) Post-challenge: one day after a-flupentixol injection, the rats
were re-exposed to the actimeter 50 minutes after i.p. injection of
NaCl 0.9%.
Statistical analyses were done using Prism (GraphPad Software,
San Diego, CA). Values (counts per 10 minutes) were compared
using the Wilcoxon matched-pairs signed ranks test.
Evaluation of catalepsy scores (bar test)
The standard bar test was used to determine the intensity of
catalepsy every 20 minutes after drug injection for 180 minutes as
previously reported [16,17]. Both of the rat’s forepaws were placed
on a horizontal bar (diameter, 0.7 cm), which was 9 cm above the
surface. We recorded the time from placing the forepaws to the
first complete removal of one of them from the support bar with a
cutoff time of 120 seconds, which is termed here as descent
latency. For rats with ibotenic acid lesion of the GP, the catalepsy
tests were made 1 week after surgery.
Extracellular single unit recordings
Extracellular single-unit recordings were made in rats anesthe-
tized with urethane (1.2 g/kg, i.p.) as previously reported [15,18].
For rats with ibotenic acid lesion of the GP, recordings were made
two weeks after surgery. For all basal ganglia nuclei recordings
were made with single glass micropipette electrodes (impedance:
8–12 MV; aperture ,0.5 mm), which were filled with 4%
Pontamine sky blue in 3 M NaCl, then placed into the right
target structure according to the coordinates given in the brain
atlas [11] (for GP, AP: 21 mm posterior to bregma, L: 23m m
from the midline, D: 5.7–7.3 mm from the dura; for STN, AP:
23.8 mm, L: 22.5 mm, D: 6.8–8.2 mm; for SNr, AP: 25.3 mm,
L: 22.5 mm, D: 7.5–8.6 mm; for striatum, AP: +1.2 mm, L:
23 mm, D: 3.5–5.5 mm). Extracellular neuronal activity was
amplified, bandpass-filtered (300–3000 Hz) using a preamplifier
(Neurolog, Digitimer, UK), displayed on an oscilloscope, trans-
ferred via a Powerlab interface (AD Instruments, Charlotte, NC,
USA) to a computer equipped with Chart 5 software (AD
Instruments, Charlotte, NC, USA). Only neuronal activity with a
signal-to-noise ratio .3:1 was recorded and used for further
investigation. Basal firing of neurons was recorded for 20 minutes
before drug injection to ascertain the stability of the discharge
activity. a-flupentixol or NaCl 0.9% (used as control) was then
injected intraperitonealy. At the end of each session, the recording
site was marked by electrophoretic injection (Iso DAM 80, WPI,
Hertfordshire, UK) of Pontamine sky blue through the micropi-
pette at a negative current of 20 mA for 7 minutes.
For recordings in the striatum, four types of neurons can be
identified. Tonically active neurons are characterized by their
unique, regularly spaced, spontaneous activity between 2 and
6 Hz. These neurons are presumed to be cholinergic interneurons.
Fast spiking GABA interneurons (FSI) are characterized by their
spike duration, which is briefer than that of all other striatal
neurons, and by the fact that they respond with brief burst of 2 to 5
action potentials to supra threshold cortical stimulation [19,20].
These two populations of striatal interneurons were not further
studied here. Our interest was focused on the two other
populations named medium spiny neurons (MSNs), which send
efferents to the GP and the SNr. Single MSNs were extracellularly
Typical APD and Basal Ganglia
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EEG recordings as previously described [20]. In urethane-
anesthetized rats the dominant cortical state exhibits a rhythmic
activity characterized by slow waves of large amplitude at a
frequency close to 1 Hz. Antidromic stimulation of the SNr was
used to identify MSNs [20]. Concentric bipolar electrodes (SNEX-
100, Rhodes Medical Instruments, Summerland, CA 93067, USA)
were implanted in the rostral pole of SNr (2.4 mm to medial line,
4.9 mm caudal to bregma and 8.0 below the cortical surface).
Striato-nigral neurons exhibited antidromic responses to SNr
stimulation according to the following criteria: (1) constant latency
of spike response, (2) all-or-none property of the spike response
when the strength of the stimulation was adjusted just above, or
just below, threshold, and (3) collision of the antidromic spikes with
orthodromic spikes. Because most striatal neurons are silent or
discharge at very low firing rate, the orthodromic spike required
for the collision test was evoked by cortical stimulation and the
SNr stimulation was triggered by the spike evoked by cortical
stimulation with a delay of 30 or 3 ms, alternately. MSNs, which
did not exhibit the features of striatal interneurons and which did
not exhibit antidromic responses to SNr stimulation were qualified
as striato-pallidal neurons [19]. By using double labeling, these
authors have already shown that these MSNs express the mRNA
coding for ENK, a recognized feature of striato-pallidal neurons
[19]. In order to test the dynamic response of MSNs to cortical
input we used paired cortical stimulations at 100 ms intervals as
previously described [19].
In all experiments described here cortical EEG was continu-
ously monitored to assert that the recorded animal was actually in
the slow wave state. If disruption of the slow waves spontaneously
occurred, the slow wave state was restored with additional i.p.
injection of urethane (15% of the initial dose). a-flupentixol
(0.3 mg/kg) or saline were administered i.p. only once per rat.
Validation of the recording sites. After completion of
experiments, animals were sacrificed by an overdose of urethane,
the brains removed, frozen in isopentane at 245uC and stored at
280uC. Fresh-frozen brains were cryostat-cut into 20 mm coronal
sections for further validation of the location of recording track into
the GP, STN and SNr as previously described [15,18]. To this aim,
acetylcholine esterase staining was used to contrast structures and
make moreeasytodeterminethelocation ofthe Pontamineskyblue
dots marking the recordingsites in each structure. Only those brains
in which the location of the Pontamine sky blue dot was clearly
visible in the target structure were used for data analysis.
Data analysis. The activity of each neuron was analyzed
with a spike discriminator using a spike histogram program (AD
Instruments, Charlotte, NC, USA) and firing parameters (firing
rates and interspike intervals with a bin of 5 msec) were calculated
using Neuroexplorer program (AlphaOmega, Nazareth, Israel).
Firing patterns were analyzed using the method based on the
determination of density histogram developed by Kaneoke and
Vitek [21] as previously described [18,22]. The coefficient of
variation of the interspike interval, which determines the regularity
of neuronal firing, is defined as the ratio of the standard deviation
to the mean interspike interval. For each parameter, the values
obtained before and after a-flupentixol injection were compared
using a one-way ANOVA with repeated measures followed by the
Dunnett’s test (post-hoc).
Results
Effects of a-flupentixol on motor activity and catalepsy
As previously reported [15], using an open field photoelectric
actimeter, the behavior of the animals was stable after three days,
indicating that the rats were habituated to their test environment.
Values are presented as mean of counts per 10 minutes6S.E.M.
Results reported as ‘‘control’’ on figure 1 correspond to the
measure on day 4 after i.p. saline injection. a-flupentixol (0.3 mg/
kg) injection significantly decreased horizontal activity by 69%
(463.8692.4 vs 1474.56225.5 in control), rearing by 75%
(13.462.8 vs 53.067.1 in control) and stereotypy by 49%
(702.6662.4 vs 1388.06172.8 in control) in comparison with
control saline injection performed on day 4 (Wilcoxon test,
p,0.01, n=10). A post-challenge test was performed on day 6
after i.p. saline injection to confirm the specific effect of a-
flupentixol. No significant difference was observed in comparison
with the motor activity measured on day 4 after saline injection
(Fig. 1A–C) confirming that the motor activity returned to the
basal level.
The cataleptic effect of a-flupentixol injection was measured
using the bar test. Catalepsy started 60 minutes after i.p. injection
of a-flupentixol (3.663.1 sec descent latency) and was maximal
180 minutes after (48.8610.1 sec descent latency) (Fig. 1D).
Effects of a-flupentixol on SNr neuronal activity
As the SNr represents the major output structure of the basal
ganglia in the rat, playing a key role in the motor control, we
determined whether systemic administration of a-flupentixol
induced changes in its neuronal activity (n=14 neurons in 14
rats). The spontaneous firing rate of SNr neurons ranged from
7.3 to 31.3 spikes/sec with a mean of 23.862.0 spikes/sec. a-
flupentixol induced a significant decrease in the firing rate
[F=4.73, p,0.0001] (255.7612.5%, at 85 minutes, p,0.05) of
the majority of SNr neurons (n=10/14) (Fig. 2 and 3). This
effect occurred 60 minutes after the injection and no recovery to
the basal level was observed (Fig. 2A and 2B). The four other
neurons did not show any modification of their firing activity
after a-flupentixol injection. As shown in figure 2C, coefficient
of variance of the intespike intervals (ISI) significantly increased
after i.p. injection of a-flupentixol [F=2.79, p=0.004]
(308.8654.0% at 75 minutes, p,0.05) traducing a disorganiza-
tion of the firing pattern of SNr neurons (Fig. 3A and 3B), which
was maintained for more than 2 hours. This abnormal pattern
of SNr neurons was confirmed by the Kaneoke and Vitek
method based on the analysis of the ISI (Fig. 3C and 3D) and
the density (Fig. 3E and 3F) histograms, which showed clear
differences before and after a-flupentixol injection in all the 10
neurons.
Effects of a-flupentixol on STN neuronal activity
The STN, which is the only glutamatergic nucleus of the basal
ganglia network, is considered as a driving force exerting an
excitatory tonic influence on the SNr. The spontaneous firing rate
of STN neurons ranged from 11.7 to 16.9 spikes/sec with a mean
of 14.661.9 spikes/sec. Responses of STN neurons to a-
flupentixol are shown in figures 4 and 5. As for the SNr, similar
changes were recorded in the STN. a-flupentixol injection
(0.3 mg/kg, i.p.) provoked a clear inhibitory effect in STN
neurons [F=4.68, p,0.0001]. All neurons (n=9/9, n=9 rats)
showed a significant decrease in their firing rate (247.065.8%, at
75 minutes, p,0.05) with a maximal effect at 115 minutes
(275.568.9%, p,0.01). This effect occurred 60 minutes after the
injection and no complete recovery to the basal level was observed
(Fig. 4A and 4B). All neurons showed a significant increase of the
coefficient of variance of the ISI [F=2.88, p=0.002]
(192.9628.1% at 100 minutes, p,0.05, n=9) suggesting that a-
flupentixol induced a disorganization of the firing pattern of STN
neurons (Fig. 4C and Fig. 5A and 5B). This was confirmed by the
Typical APD and Basal Ganglia
PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6208Figure 1. a-flupentixol induces hypomotor activity and catalepsy. (A–C) Histograms illustrating the scored motor activity recorded during
the second 10 minutes session fifty minutes after the injection of saline (control) or a-flupentixol (0.3 mg/kg) or saline on day 4, 5 and 6 respectively.
Note that a-flupentixol induced a significant decrease of the scored horizontal activity (A), vertical activity (B) and stereotypic movements (C) in
comparison with controls (n=10 rats) (Wilcoxon test, **p,0.01). No significant difference was observed after saline injection on day 6 in comparison
with controls (Wilcoxon test, ns: no-significant, p.0.05). (D) Histogram displaying the evolution of catalepsy induced by the injection of a-flupentixol.
Measurement of the latency from paw placement until the first complete removal of one paw from the bar during the catalepsy test. Values are
presented as the mean6S.E.M. cts/10 min=counts/10 minutes.
doi:10.1371/journal.pone.0006208.g001
Typical APD and Basal Ganglia
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(Fig. 5C and 5D) and the density (Fig. 5E and 5F) histograms,
which showed clear differences before and after a-flupentixol
injection.
We suspected that the changes in SNr and STN neuronal
activities originated at an upstream location. As a part of the
indirect pathway, GP exerts a tonic inhibitory influence on both
STN and SNr.
Figure 2. a-flupentixol induces changes of the electrical activity of substantia nigra pars reticulata neurons. (A) A representative
example of a firing rate histogram showing the inhibitory effect of a-flupentixol on SNr neuronal activity. (B) a-flupentixol decreases the firing rate of
the majority of SNr neurons tested (n=10/14), and (C) increases the coefficient of variance of the interspike interval (ISI) (One-way ANOVA with
repeated measures followed by the Dunnett’s test, *p,0.05). Arrows indicate the time at which a-flupentixol was administred.
doi:10.1371/journal.pone.0006208.g002
Typical APD and Basal Ganglia
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The spontaneous firing rate of GP neurons ranged from 9.7
to 24.1 spikes/sec. with a mean of 13.462.1 spikes/sec.
Responses of GP neurons to a-flupentixol are shown in
figure 6 and 7. a-flupentixol injection (0.3 mg/kg) induced a
clear excitatory effect on GP neurons [F=4.08, p=0.0003]
(Fig. 6 and 7). All of the tested neurons (n=9/9, n=9 rats)
showed a significant increase in their firing rate (+50.4610.5%
at 65 minutes, p,0.05) in comparison with the basal level. The
effect was maintained for more than two hours (Fig. 6A–B). No
change in the coefficient of variance of the ISI was observed
[F=0.20, p=0.99] (Fig. 6C) showing that the regularity of the
pattern was not altered (Fig.7A and 7B). This result was
confirmed by the Kaneoke and Vitek method based on the
analysis of the ISI (Fig. 7C and 7D) and the density (Fig. 7E and
7F) histograms, which showed no differences before and after a-
flupentixol injection.
Effects of a-flupentixol on MSNs of the striatum
Since the GP receives GABAergic afferents from striato-pallidal
MSNs of the striatum and that another neuronal subset, the
striato-nigral MSNs, projects to the SNr, we recorded these two
populations after their antidromic identification as previously
reported [19]. Six neurons (n=6 rats) were identified as striato-
Figure 3. a-flupentixol alters the firing patterns of substantia nigra pars reticulata neurons. (A and B) Sections of extracellular recordings
of action potentials, before and after injection respectively, showing that a-flupentixol reduced the firing rate and made the pattern irregular. (C and
D) Interspike interval histograms, (E and F) density histograms, respectively before and after a-flupentixol injection confirming the disorganization of
the firing pattern induced by a-flupentixol in the same neuron.
doi:10.1371/journal.pone.0006208.g003
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PLoS ONE | www.plosone.org 6 July 2009 | Volume 4 | Issue 7 | e6208Figure 4. a-flupentixol induces changes of electrical activity of subthalamic nucleus neurons. (A) A representative example of a firing rate
histogram showing the inhibitory effect of a-flupentixol on STN neuronal activity. (B) a-flupentixol decreases the firing rate of all STN neurons tested
(n=9/9), and (C) increases the coefficient of variance of the interspike interval (ISI) (One-way ANOVA with repeated measures followed by the
Dunnett’s test, *p,0.05, **p,0.01). Arrows indicate the time at which a-flupentixol was administred.
doi:10.1371/journal.pone.0006208.g004
Typical APD and Basal Ganglia
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other MSNs (n=7 rats) that did not exhibit an antidromic
response to SNr stimulation were not classified as interneurons
and were identified as striato-pallidal MSNs. Responses to a-
flupentixol were recorded between 40 and 120 minutes after i.p.
injection. a-flupentixol did not induce any significant change in
the spontaneous firing rate of striato-pallidal MSNs (F=0.28,
p=0.76, n=6, Fig. 8B left) nor of striato-nigral MSNs (F=0.66,
p=0.53, n=7, Fig. 8C left). As most of MSNs are silent or
discharge at very low firing rate, (this can explain the high level of
error bars of the firing rate histograms) the effect of a-flupentixol
was studied on the responses evoked by cortical stimulations. a-
flupentixol (0.3 mg/kg) decreased the spike responses evoked in
striato-pallidal MSNs by the second pulse of paired cortical
stimulations (p=0.031, Fig. 8B middle). Indeed, the stimulating
current required to evoke a spike response with a 50% probability
was significantly increased after a-flupentixol injection (p=0.031,
Fig. 8B right). Regarding the striato-nigral MSNs, neither the
spike response evoked by cortical stimulations, nor the stimulating
current to evoke a spike response with a 50% probability was
modified (p=0.437 and p=0.843 respectively, Fig. 8C middle and
right respectively).
Together, our electrophysiological data show that the indirect
pathway, but not the direct pathway, is suspected to play an
Figure 5. a-flupentixol alters the firing patterns of subthalamic nucleus neurons. (A and B) Sections of extracellular recordings of action
potentials, before and after injection respectively, showing that a-flupentixol reduced the firing rate and made the pattern irregular. (C and D)
Interspike interval histograms, (E and F) density histograms, respectively before and after a-flupentixol injection confirming the disorganization of the
firing pattern induced by a-flupentixol in the same neuron.
doi:10.1371/journal.pone.0006208.g005
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6208important role in the manifestation of EPS induced by a-
flupentixol. To test this hypothesis, we investigated the effect of
selective ibotenic acid lesion of the GP, which is a relay structure in
the indirect pathway on a-flupentixol-induced catalepsy and
changes in STN neuronal activity.
Effects of GP lesion on a-flupentixol-induced catalepsy
and changes in STN neuronal activity
Cresyl violet staining of coronal sections allowed us to determine
the extent of ibotenic acid lesion of GP and only rats with a total or
subtotal lesion of the nucleus (Fig. 9A and 9B) were selected for the
Figure 6. a-flupentixol induces changes of electrical activity of globus pallidus neurons. (A) A representative example of a firing rate
histogram showing the excitatory effect of a-flupentixol on GP neuronal activity. (B) a-flupentixol increases the firing rate of all GP neurons tested
(n=9/9), without any modification of the coefficient of variance of the interspike interval (ISI) (C) (One-way ANOVA with repeated measures followed
by the Dunnett’s test, *p,0.05). Arrows indicate the time at which a-flupentixol was administred.
doi:10.1371/journal.pone.0006208.g006
Typical APD and Basal Ganglia
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measurements showed that after selective ibotenic acid lesions of
the GP, a-flupentixol (0.3 mg/kg) failed to induce catalepsy
(n=9 rats) (Fig. 9C). In these animals, the spontaneous firing
rate of STN neurons ranged from 10.3 to 38.9 spikes/sec with a
mean of 19.864.1 spikes/sec (n=6, in six rats). a-flupentixol
(0.3 mg/kg) did not induce any change in the firing rate
[F=0.68, p=0.77] (Fig. 9D) nor in the firing patterns of STN
neurons as shown by the coefficient of variance of the ISI
[F=2.50, p=0.41] (Fig. 9E).
Discussion
The present study reports for the first time important
experimental evidence for a key role of the basal ganglia network
in the manifestation of EPS induced by typical APDs. Indeed, the
hypoactivity accompanied by irregular discharge patterns record-
ed in the STN and the SNr appears to be a specific consequence of
increased neuronal activity within the globus pallidus, suggesting
that the indirect pathway, but not the direct pathway, plays an
important role in the motor effects of a-flupentixol.
Figure 7. a-flupentixol does not alter the firing patterns of globus pallidus neurons in vivo. (A and B) Sections of extracellular recordings
before and after injection respectively, showing that a-flupentixol increased the firing rate without modifying the firing pattern. (C and D) Interspike
interval histograms, (E and F) density histograms, respectively before and after a-flupentixol injection confirming the absence of changes of the firing
pattern in the same neuron.
doi:10.1371/journal.pone.0006208.g007
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PLoS ONE | www.plosone.org 10 July 2009 | Volume 4 | Issue 7 | e6208Figure 8. Responses of identified striatal MSNs to a-flupentixol. (A) Electrophysiological identification of striato-nigral neurons. Example of a
collision test used to identify a striato-nigral neuron by antidromic activation of the SNr. The SNr stimulation (SNr) was triggered by an orthodromic
spike evoked by cortical stimulation (Cx) either with a delay of 30 ms (no collision) or with a delay of 3 ms leading to collision of both spikes. (B) and
(C) Responses of striato-pallidal (n=7) and striato-nigral cells (n=6) respectively. The left pannel histograms show the spontaneous activity of MSNs,
whereas midle and right pannel represent repectively the spike propability response at a fixed cortical stimulating current and the stimulating current
required to evoke a spike response with a 50% probability, both, before and after a-flupentixol injection. Note that a-flupentixol did not induce any
significant change in the spontaneous firing rate of striato-pallidal MSNs (One way ANOVA, F=0.28, p=0.76) nor of striato-nigral MSNs (One way
ANOVA, F=0.66, p=0.53). However, striato-pallidal MSNs were less responsive to cortical stimulations (p=0.031) and the stimulating current required
to evoke a spike response with a 50% probability was significantly increased after a-flupentixol injection (p=0.031). Bar histograms indicate
mean6S.E.M., *p,0.05, ns: non-significant.
doi:10.1371/journal.pone.0006208.g008
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decrease in the motor activity parameters measured by the open
field actimeter. These results confirm the ability of this APD to
induce EPS in the rat in agreement with previous reports using a-
flupentixol [13] or other typical APDs such as haloperidol [23],
raclopride [24,25] and sulpiride [26]. Several studies suggested
that typical APDs have a high EPS liability because they generally
induce a more pronounced dopamine D2 receptor occupancy
than atypical APDs [27–31]. Indeed, haloperidol does not induce
catalepsy in D2 knockout mice [32], demonstrating that EPS are
specifically due to the blockade of D2 receptors. In line with this,
a-flupentixol has been shown to have a higher affinity for D2 than
D1 receptors in vivo [33].
According to the proposed anatomo-functional model of the
motor circuit [5], the blockade of dopamine receptors, which
mimics the nigro-striatal denervation in animal models of
Parkinson’s disease, should result in similar changes in basal ganglia
network function, i.e. hyperactivity associated with bursty activity in
the major output structure of basal ganglia, the SNr [34–36]. This
hyperactivity has been interpreted as a result of reduced inhibitory
input from the striatum via the direct pathway implicating D1
receptors and a release of the inhibitory input from the striatum to
the GP via D2 receptors of the indirect pathway [5,8,19,37]. The
decrease in neuronal activity of GP neurons, in turn, induces a
disinhibition of STN neurons becoming overactive, and conse-
quently spreads this hyperactivity to SNr neurons. Surprisingly, our
electrophysiological findings show that the cascade of changes
recorded in different nuclei of the basal ganglia network after the
administration of a-flupentixol is dissimilar to those previously
found in animal models of parkinsonism.
We show that a-flupentixol did not induce an increase but a
dramatic decrease in the firing rate of SNr neurons, which was
Figure 9. Globus pallidus lesion prevents a-flupentixol-induced catalepsy and changes in the neuronal activity of STN neurons. (A
and B) Photomicrographs of the globus pallidus showing the control side (A) and the side which received ibotenic acid injection-induced cell death
(B, lesioned side). Scale bar: 50 mm. (C) Histogram illustrating the mean6S.E.M of the latency measured from paw placement until the first complete
removal of one paw from the bar during the catalepsy testing (n=9). Note that ibotenic acid lesion of the globus pallidus prevents a-flupentixol-
induced catalepsy. (D and E) Curves illustrating the evolution of the firing rate (D) and the coefficient of variance (E) after the injection of a-flupentixol
(arrow) in rats (n=6) with ibotenic acid lesion of the globus pallidus. Note that this lesion prevented the alteration of the two electrophysiological
parameters (One-way ANOVA with repeated measures, p.0.05). Values are presented as the mean6S.E.M.
doi:10.1371/journal.pone.0006208.g009
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as determined by the coefficient of variance of the ISI and also by
the Kaneoke and Vitek method [21]. As the striatum constitutes
the major input structure of the basal ganglia network, we
recorded the spontaneous activity of identified MSNs at the origin
of the direct pathway connecting the striatum to the SNr. Our
results show that a-flupentixol was unable to induce any significant
change in the spontaneous activity of these identified striato-nigral
MSNs and even with cortical stimulations no change in the evoked
response was observed. Indeed, it is unlikely that the direct
pathway is the origin of changes observed in the SNr. However, in
the STN, which is a part of the indirect pathway and at the same
time a major excitatory afferent component of the SNr, a-
flupentixol induced a dramatic decrease in the firing rate with a
disorganization of the firing pattern similar to those recorded in
the SNr. From these results, and in accordance with the
glutamatergic nature of STN-SNr transmission responsible for
the tonic discharge of SNr neurons (for review, [38]), we can
postulate that the decrease in the firing rate of STN neurons could
result in a deactivation of SNr neurons with a propagation of
irregular discharge patterns. This fit with the results of a previous
study, which showed that pharmacological blockade of STN
neuronal activity resulted in a marked reduction in SNr firing [39].
Moreover, we add evidence that the changes in STN neuronal
activity could originate in the GP as we show that a-flupentixol
induced an increase in the firing rate of GP neurons. It is well
known that STN neurons receive inhibitory GABAergic afferents
from the GP [40,41] and that the increase in the activity of GP
neurons could result in an increase of GABA release in this
nucleus. These results represent additional evidence for neurolep-
tic-induced increase of the GP neuronal activity in agreement with
other studies using quantitative in situ hybridization of GAD67
mRNA expression, which is an index of GABAergic activity [42].
The firing rate increase of GP neurons can be also implicated in
the decreased neuronal activity recorded in the SNr, since neurons
of this nucleus receive dense GABAergic inputs from GP [43],
which converge with subthalamo-nigral terminals on the same
SNr neurons [44].
While considering how a-flupentixol influences GP activity, it is
impossible to ignore the contribution of striatal MSNs. GP
neurons receive inhibitory input from striatal MSNs expressing D2
receptors [5,8,37]. However, our electrophysiological results show
that a-flupentixol did not induce any significant change in the
spontaneous activity of striato-pallidal MSNs. Nevertheless, during
cortical activation the decrease of the evoked response of striato-
pallidal MSNs after the injection of a-flupentixol can reinforce the
disinhibition of GP neuronal activity. Thus, at basal conditions,
the possible mechanism could be mediated by the direct alteration
of dopamine transmission in GP as its neurons express mostly D2
receptors [45]. In agreement with this hypothesis, previous studies
have shown that systemic administration of D2 antagonists
induced Fos expression, the protein product of the immediate
early gene c-fos, in the GP by its direct action within GP and not
within the striatum [3,4,46]. Moreover, dopamine transmission
within the GP has been shown to be necessary to achieve motor
control. Bilateral blockade of dopamine transmission into the GP
induced akinesia and catalepsy [26,47]. However, the infusion of
dopamine in the same nucleus caused improvement of motor
deficits in hemiparkinsonian rats [48].
Together, our results suggest that EPSs are correlated with
changes in two major structures of the basal ganglia network, the
STN and SNr and that these changes may be a consequence of the
increased firing rate of GP neurons. This hypothesis was
confirmed by our data showing that after selective ibotenic acid
lesions of the GP, a-flupentixol failed to induce catalepsy and
concomitantly any changes in subthalamic neuronal activity
demonstrating the key role of the indirect pathway in the
manifestation of EPS. These results are in line with previous
studies showing that inactivation of the GP can elicit motor
activation or reverse motor hypoactivity. Indeed, GP lesions have
been shown to abolish neuroleptic-induced catalepsy [49–51].
In conclusion our results emphasize the key role of changes
occurring in basal ganglia network implicated in the manifestation
of EPS induced by a typical APD, demonstrating that hypokinesia
and catalepsy-induced by a-flupentixol are clearly associated with
hypoactivity and abnormal irregular patterns of STN and SNr
neurons. The changes observed in these two nuclei are not
mediated by MSNs of the striatum. Moreover, our study provides
new insight into the role of GP, which is a key structure of the
indirect pathway, in the pathophysiology of APD-induced EPS
and that GP can be considered as a potential target for the
treatment of EPS.
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